It is the first time an immune system-related product has been registered in Japan. When registration is accepted by the CAA, labeling of “function claims” (usually health benefits) on products becomes possible.
The products covered are three soft drinks and two supplements, to be announced at a later date.
The Lactococcus lactis strain Plasma is a type strain of Lactococcus lactis, a natural lactic acid bacterium mainly used for the fermentation of cheese and yogurt.
Moving forward, Kirin Group said it will accelerate domestic sales as well as expand overseas sales of products that utilize Lactococcus lactis strain Plasma, leading to further contribution to the health and well-being of the global community.
The Lactococcus lactis strain Plasma is a product of joint research by Kirin Holdings, Koiwai Dairy Products, and Kyowa Hakko Bio.
The company said its products will be able to state “This product contains Lactococcus lactis strain Plasma. It has been shown to support maintenance of the immune system in healthy individuals by stimulating pDC (plasmacytoid dendritic cells).”
On packaging, it said it will be able to print “Supports maintenance of the immune system in healthy individuals.”